Medmix AGMDMXF 61 EBIT per Share is $0.57 as of Dec. 2025. GuruFocus rates MDMXF with a GF Score™ of 61/100 and a GF Value™ of $26.13. The stock has 7 warning signs investors should review. Among 2,500 Industrial Products companies, Medmix AG ranks worse than 79.84% on this metric.
Medmix AG's EBIT per Share for the
six
months ended in Dec. 2025 was $0.18.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.57.
During the past 12 months, the average EBIT per Share Growth Rate of Medmix AG was 53.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -17.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -9.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medmix AG's EBIT per Share or its related term are showing as below:
MDMXF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -34.1 Med: -11.3 Max: -2
Current: -17.7
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Medmix AG was -2.00% per year. The lowest was -34.10% per year. And the median was -11.30% per year.
MDMXF's 3-Year EBIT Growth Rate is ranked worse than 79.84% of 2500
companies
in the Industrial Products industry
Industry Median: 4.8
vs MDMXF: -17.70
Medmix AG's EBIT for the
six
months ended in Dec. 2025 was $7.3 Mil.
Medmix AG (OTCPK:MDMXF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medmix AG EBIT per Share Related Terms
Medmix AG EBIT per Share Historical Data
* Premium members only.
The historical data trend for Medmix AG's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (MDMXF) has a EBIT per Share of $0.57 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medmix AG and its competitors. According to the industry distribution chart, Medmix AG ranks #1996 out of 2500 companies in the Industrial Products industry, placing it in the top 79.8%.
Is Medmix AG's EBIT per Share too high?
Medmix AG's current EBIT per Share is $0.57. The Industrial Products industry median EBIT per Share is 4.80. Medmix AG's value of $0.57 is 88.1% below this industry median. Based on the distribution chart, Medmix AG ranks #1996 out of 2500 companies in the Industrial Products industry, which is in the bottom quartile relative to peers. Overall, Medmix AG has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's EBIT per Share compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #1996 out of 2500 companies for EBIT per Share. This places Medmix AG in the lower half of its industry. The industry median EBIT per Share is 4.80. Medmix AG's value of $0.57 is 88.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for an Industrial Products company?
The median EBIT per Share among Industrial Products companies is 4.80, based on 2,500 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current EBIT per Share of $0.57 is 88.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median EBIT per Share is 4.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current EBIT per Share is $0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current EBIT per Share of $0.57. The stock's GF Value™ is $26.13, compared to a current price of $17.40 — trading 33.4% below its estimated fair value. The current EBIT per Share is $0.57 and 88.1% below the Industrial Products industry median of 4.80. Medmix AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Medmix AG (MDMXF), the current EBIT per Share is $0.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (MDMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.
Key valuation signals for MDMXF:
EBIT per Share: $0.57
GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
Industry Position: 88.1% below the Industrial Products median (#1996 of 2500)
No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score
Get the complete analysis for MDMXF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDMXF has been successfully added to your 
